« Looking good! Novo Nordisk releases LEAD liraglutide data early, pre-ADA - shows superiority (rather than just non-inferiority) over Lantus | Main | Obesity abounds, new maps out »
Read our blog on Day One at http://www.revolutionhealth.com/blogs/kellyclose/
The comments to this entry are closed.
Comments